Carbimazole 5mg tablets

Pajjiż: Ingilterra

Lingwa: Ingliż

Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredjent attiv:

Carbimazole

Disponibbli minn:

Advanz Pharma

Kodiċi ATC:

H03BB01

INN (Isem Internazzjonali):

Carbimazole

Dożaġġ:

5mg

Għamla farmaċewtika:

Oral tablet

Rotta amministrattiva:

Oral

Klassi:

No Controlled Drug Status

Tip ta 'preskrizzjoni:

Valid as a prescribable product

Sommarju tal-prodott:

BNF: 06020200; GTIN: 5060064172025

Karatteristiċi tal-prodott

OBJECT 1
CARBIMAZOLE 5 MG TABLETS
Summary of Product Characteristics Updated 20-Apr-2021 | ADVANZ Pharma
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Carbimazole 5 mg Tablets
2. Qualitative and quantitative composition
Each tablet contains 5 mg of carbimazole.
Excipients with known effect:
Lactose Anhydrous (140.485 mg per tablet)
For a full list of excipients see section 6.1.
3. Pharmaceutical form
Pale pink, uncoated, round, biconvex tablets marked with LINK C5 on
one side and a scoreline on the
reverse.
The score line is only to facilitate breaking for ease of swallowing
and not to divide into equal doses.
4. Clinical particulars
4.1 Therapeutic indications
Carbimazole is an anti-thyroid agent. It is indicated in adults and
children in all conditions where reduction
of thyroid function is required.
Such conditions are:
1. Hyperthyroidism.
2. Preparation for thyroidectomy in hyperthyroidism.
3. Therapy prior to and post radio-iodine treatment.
4.2 Posology and metho